Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.

< BACK TO ARCHIVE


Papers: 22 Jan 2022 - 28 Jan 2022


Human Studies, Pharmacology/Drug Development


2022 Jan 25


Headache


http://www.ncbi.nlm.nih.gov/pubmed/35076091?dopt=Abstract

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.

Authors

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.
Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE, Buse DC, Shapiro RE, Ashina S, Cambron-Mellott JM, Rowland JC, Pearlman EM
Headache. 2022 Jan 25.
PMID: 35076091.

Abstract

The ObserVational survey of the Epidemiology, tReatment and Care of MigrainE (OVERCOME; United States) study is a multicohort, longitudinal web survey that assesses symptomatology, consulting, diagnosis, treatment, and impact of migraine in the United States.
Read This Paper